Phase 1 Trial of Concurrent Sunitinib and Radiation Therapy as Preoperative Treatment for Locally Advanced or Recurrent Soft Tissue Sarcoma.
Phase of Trial: Phase I
Latest Information Update: 02 Jun 2015
At a glance
- Drugs Sunitinib (Primary)
- Indications Dermatofibrosarcoma; Ewing's sarcoma; Haemangiosarcoma; Rhabdomyosarcoma; Soft tissue sarcoma
- Focus Adverse reactions
- Acronyms SunRaSe
- 02 Jun 2015 Results presented at the 51st Annual Meeting of the American Society of Clinical Oncology.
- 10 Feb 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 10 Feb 2012 Actual initiation date (February 2012) added as reported by ClinicalTrials.gov.